AMG531

romiplostim · Kyowa Kirin Korea Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AMG531, covering 2021-02-15 to 2022-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of AMG531(Romiplostim) in Patients With Aplastic Anemia [Phase 2, Phase 3]